Koelbl Christian O, Nedeljkovic Zoran S, Jacobs Alice K
Columbia University Division of Cardiology Mount Sinai Heart Institute 4300 Alton Road De Hirsch Meyer Tower Suite 2070 Miami Beach, FL 33140, USA.
Section of Cardiology Boston Medical Center 88 East Newton Street Boston, Massachusetts 02118-2393, USA.
Rev Cardiovasc Med. 2018 Mar 30;19(1):33-39. doi: 10.31083/j.rcm.2018.01.896.
Coronary artery chronic total occlusions (CTO) are frequently encountered during coronary angiography; however percutaneous recanalization has historically been technically challenging and an important determinant for referral to coronary artery bypass surgery or for medical therapy alone. Recent advances in interventional equipment and innovative approaches to crossing CTO have significantly increased the success rate of percutaneous treatment. Although there is only one relevant randomized control trial (RCT) performed to date, several large, nonrandomized studies have consistently reported improvement in clinical outcomes, including improved survival and relief of angina, when successful percutaneous treatment of CTO was compared with unsuccessful revascularization. These positive observational results have encouraged the initiation of several RCTs which will provide more robust evidence on clinical outcomes of CTO-PCI compared with guideline-directed medical therapy (GDMT) alone.
冠状动脉慢性完全闭塞(CTO)在冠状动脉造影中经常遇到;然而,从历史上看,经皮再通在技术上具有挑战性,并且是决定转诊至冠状动脉搭桥手术或仅接受药物治疗的一个重要因素。介入设备的最新进展以及穿越CTO的创新方法显著提高了经皮治疗的成功率。尽管迄今为止仅进行了一项相关的随机对照试验(RCT),但多项大型非随机研究一致报告称,将CTO的成功经皮治疗与不成功的血运重建进行比较时,临床结局有所改善,包括生存率提高和心绞痛缓解。这些积极的观察结果促使开展了多项RCT,这些试验将提供更有力的证据,以比较CTO-PCI与单纯指南指导的药物治疗(GDMT)的临床结局。